Clinical Trial Update: A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reporting results of a study comparing concentrations of anidulafungin and voriconazole in the lungs after intravenous dosing in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspergillosis
• Candidemia

Drugs mentioned

• Eraxis (anidulafungin)
• VFEND (Voriconazole)

Snippet

Sponsor: Pfizer | Conditions: Aspergillosis, Candidemia | Phase 4 | Status: COMPLETED | Results posted: 2010-02-09